|
|
Omega 3-6-9 1000 mg - 100 Gels |
| |
|
| Omega 3-6-9 1000 mg - 100 Gels |
|
| $8.35 |
| 66-1835 |
|
|
|
| Description: |
Essential Fatty Acids Supports Cardiovascular Health* Hexane Free Nutritional Oils This NOW product provides a balanced blend of two essential polyunsaturated fatty acids (and their derivatives) necessary for many body functions:
Omega-3 oil from Flax Seed and Canola, and Omega-6 oil (GLA) from Primrose and Black Currant.
Oleic Acid, an Omega-9 oil from Canola and Flax Seed, is a monounsaturated fat not considered "essential" but does play beneficial roles in human health.
From the FDA's website: "Consumption of omega-3 fatty acids may reduce the risk of coronary heart disease. FDA evaluated the data and determined that, although there is scientific evidence supporting the claim, the evidence is not conclusive (see nutrition information for fat content)".
Read more about Omega-3 Fish Oils from Your Health Professor
Product FAQ's
Related Products
Serving Size:
2 Softgels
Servings Per Container:
50 Suggested Usage:
As a dietary supplement, take 2 softgels 1 to 3 times daily with meals.
Consider taking this product in combination with NOW© Tru-E BioComplex©, CoQ10 and Alpha Lipoic Acid. Other Ingredients:
Softgel Capsule (gelatin, glycerin, water, carob).
Contains no:
sugar, salt, starch, yeast, wheat, gluten, corn, soy, milk, egg, shellfish or preservatives. Caution:
Do Not Eat Freshness Packet.
Keep in Bottle. Disclaimers:
*This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Natural color variations may occur in this product. Each serving may also provide the following naturally occurring amounts of polyunsaturated fats and monounsaturated fats:
Omega-3 oils:
Alpha Linolenic Acid (ALA) - 900 mg Omega-6 oils:
Linoleic Acid and Gamma Linolenic Acid (GLA) - 530 mg Omega-9 oils:
Oleic Acid - 350 mg Other oils:
Short chain fatty acids, saturated fats, phospholipids, etc. - 220 mg
Store in a cool, dry place.
Please Recycle. |
|
|
|
|
